Beacon Pointe Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.14M | Sell |
16,029
-196
| -1% | -$87.3K | 0.07% | 237 |
|
|
2025
Q1 | $7.87M | Buy |
16,225
+22
| +0.1% | +$10.7K | 0.09% | 210 |
|
|
2024
Q4 | $6.52M | Sell |
16,203
-793
| -5% | -$319K | 0.07% | 222 |
|
|
2024
Q3 | $7.9M | Sell |
16,996
-2,185
| -11% | -$1.02M | 0.09% | 193 |
|
|
2024
Q2 | $8.99M | Sell |
19,181
-8
| -0% | -$3.75K | 0.11% | 175 |
|
|
2024
Q1 | $8.02M | Sell |
19,189
-75
| -0.4% | -$31.4K | 0.09% | 204 |
|
|
2023
Q4 | $7.84M | Sell |
19,264
-813
| -4% | -$331K | 0.09% | 191 |
|
|
2023
Q3 | $6.98M | Buy |
20,077
+724
| +4% | +$252K | 0.09% | 209 |
|
|
2023
Q2 | $6.81M | Sell |
19,353
-1,753
| -8% | -$617K | 0.11% | 172 |
|
|
2023
Q1 | $6.65M | Sell |
21,106
-5,230
| -20% | -$1.65M | 0.11% | 176 |
|
|
2022
Q4 | $7.61M | Sell |
26,336
-546
| -2% | -$158K | 0.15% | 140 |
|
|
2022
Q3 | $7.79M | Sell |
26,882
-297
| -1% | -$86.1K | 0.17% | 132 |
|
|
2022
Q2 | $7.66M | Sell |
27,179
-753
| -3% | -$212K | 0.16% | 137 |
|
|
2022
Q1 | $7.29M | Buy |
27,932
+5,414
| +24% | +$1.41M | 0.1% | 195 |
|
|
2021
Q4 | $4.95M | Sell |
22,518
-6,314
| -22% | -$1.39M | 0.13% | 145 |
|
|
2021
Q3 | $5.23M | Buy |
28,832
+17,845
| +162% | +$3.24M | 0.13% | 167 |
|
|
2021
Q2 | $2.22M | Buy |
10,987
+9,536
| +657% | +$1.92M | 0.08% | 203 |
|
|
2021
Q1 | $313K | Buy |
1,451
+70
| +5% | +$15.1K | 0.02% | 378 |
|
|
2020
Q4 | $327K | Sell |
1,381
-183
| -12% | -$43.3K | 0.02% | 350 |
|
|
2020
Q3 | $426K | Buy |
1,564
+162
| +12% | +$44.1K | 0.04% | 246 |
|
|
2020
Q2 | $408K | Buy |
1,402
+13
| +0.9% | +$3.78K | 0.04% | 263 |
|
|
2020
Q1 | $329K | Buy |
+1,389
| New | +$329K | 0.05% | 224 |
|